Search research articles
Contact Us
Filters
Showing results (331-340 of 345) with videos related to
Page
of 35
Sort By:
Chemical Science
|
August 5, 2021
A palladium-catalyzed approach to allenic aromatic ethers and first total synthesis of terricollene A
Chaofan Huang, Fuchun Shi, Yifan Cui, et al.
Nature Communications
|
January 19, 2020
TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh
Limin Zhao, Hao Ke, Haibo Xu, et al.
Nature Communications
|
February 7, 2020
Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate
Xue Wang, Haibo Xu, Chaping Cheng, et al.
General Psychiatry
|
December 26, 2025
Global burden of mental disorders among adolescents and young adults, 1990-2021: a systematic analysis of the Global Burden of Diseases Study 2021
Jiayi Tian, Na Yan, Xinyi Hu, et al.
European Radiology
|
April 29, 2021
Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging
Sirui Li, Yuan Zheng, Wenbo Sun, et al.
Journal of Alzheimer'S Disease : JAD
|
June 29, 2026
Glymphatic system metrics derived from DTI-ALPS are associated with cognitive impairment, brain atrophy, and plasma tauopathy biomarkers of type 2 diabetes patients: Analysis in dual-cohort
Yang Gao, Weiqiang Liang, Gandig Wang, et al.
Cell Metabolism
|
April 9, 2020
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
Dan Liu, Peng Zhang, Junjie Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 16, 2021
Patient-Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
Zhichao Li, Haibo Xu, Yanqing Gong, et al.
Gut
|
November 27, 2025
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD
Toujun Zou, Juan Wan, Rufang Liao, et al.
The Journal of Clinical Investigation
|
September 2, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis
Xiao-Jing Zhang, Jiajun Fu, Xu Cheng, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 345) with videos related to
Sort By:
Page
of 35
Chemical Science
|
August 5, 2021
A palladium-catalyzed approach to allenic aromatic ethers and first total synthesis of terricollene A
Chaofan Huang, Fuchun Shi, Yifan Cui, et al.
Nature Communications
|
January 19, 2020
TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh
Limin Zhao, Hao Ke, Haibo Xu, et al.
Nature Communications
|
February 7, 2020
Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate
Xue Wang, Haibo Xu, Chaping Cheng, et al.
General Psychiatry
|
December 26, 2025
Global burden of mental disorders among adolescents and young adults, 1990-2021: a systematic analysis of the Global Burden of Diseases Study 2021
Jiayi Tian, Na Yan, Xinyi Hu, et al.
European Radiology
|
April 29, 2021
Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging
Sirui Li, Yuan Zheng, Wenbo Sun, et al.
Journal of Alzheimer'S Disease : JAD
|
June 29, 2026
Glymphatic system metrics derived from DTI-ALPS are associated with cognitive impairment, brain atrophy, and plasma tauopathy biomarkers of type 2 diabetes patients: Analysis in dual-cohort
Yang Gao, Weiqiang Liang, Gandig Wang, et al.
Cell Metabolism
|
April 9, 2020
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
Dan Liu, Peng Zhang, Junjie Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 16, 2021
Patient-Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
Zhichao Li, Haibo Xu, Yanqing Gong, et al.
Gut
|
November 27, 2025
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD
Toujun Zou, Juan Wan, Rufang Liao, et al.
The Journal of Clinical Investigation
|
September 2, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis
Xiao-Jing Zhang, Jiajun Fu, Xu Cheng, et al.
Page
of 35